Cam Gallagher, Director at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 17,600 shares at $75.02 ($1.3M) on 2021-11-15, disclosed to the SEC on 2021-11-16.
Open-market sale of $1.3M ZNTL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.02 | 6,614 | $496K | 37.4% |
| 2 | $75.02 | 6,614 | $496K | 37.4% |
| 3 | $75.76 | 2,400 | $182K | 13.7% |
| 4 | $76.67 | 986 | $76K | 5.7% |
| 5 | $76.67 | 986 | $76K | 5.7% |
| Total | $75.31 avg | 17,600 |
| $1.3M |
| 100% |
| Filing → |
| ZNTL | SELL | 2024-02-12 | $13K | — | Filing → |
| ZNTL | SELL | 2024-02-05 | $267K | — | Filing → |
| ZNTL | SELL | 2023-05-31 | $1.5M | — | Filing → |